Skip to main content
SpringerLink
Log in

Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives

  • Meeting Report
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Trifirò G, Sultana J, Bate A. From big data to smart data for pharmacovigilance: the role of healthcare databases and other emerging sources. Drug Saf. 2018;41(2):143–9.

    Article  PubMed  Google Scholar 

  2. Mazzitello C, Esposito S, De Francesco AE, Capuano A, Russo E, De Sarro G. Pharmacovigilance in Italy: an overview. J Pharmacol Pharmacother. 2013;4(Suppl 1):S20–8.

    PubMed  PubMed Central  Google Scholar 

  3. Spontaneous reporting keeps growing in Italy. Focus Farmacovigilanza 2013;76(5):2. https://www.pharmaco-vigilance.eu/content/spontaneous-reporting-keeps-growing-italy.

  4. van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, Schutte T, Tanaka D, van Puijenbroek E, Härmark L. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ferner RE. The influence of big pharma. BMJ. 2005;330(7496):855–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. de Vries ST, Denig P, Lasheras Ruiz C, Houÿez F, Wong L, Sutcliffe A, Mol PGM, IMI Web-RADR Work Package 3b Consortium. Interest in a mobile app for two-way risk communication: a survey study among European healthcare professionals and patients. Drug Saf. 2018;41(7):697–712.

    Article  PubMed  PubMed Central  Google Scholar 

  7. de Vries ST, van der Sar MJM, Cupelli A, Baldelli I, Coleman AM, Montero D, Šipić I, Andrić A, Wennberg A, Ahlqvist-Rastad J, Denig P, Mol PGM, SCOPE Work Package 6. Communication on safety of medicines in Europe: current practices and general practitioners’ awareness and preferences. Drug Saf. 2017;40(8):729–42.

    Article  PubMed  PubMed Central  Google Scholar 

  8. de Vries ST, van der Sar MJM, Coleman AM, Escudero Y, Rodríguez Pascual A, Maciá Martínez MÁ, Cupelli A, Baldelli I, Šipić I, Andrić A, Michan L, Denig P, Mol PGM, SCOPE Work Package 6. Safety communication tools and healthcare professionals’ awareness of specific drug safety issues in Europe: a survey study. Drug Saf. 2018;41(7):713–24.

    Article  PubMed  PubMed Central  Google Scholar 

  9. McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM. Mini-Sentinel methods: framework for assessment of positive results from signal refinement. Pharmacoepidemiol Drug Saf. 2014;23(1):3–8.

    Article  PubMed  Google Scholar 

  10. Belleudi V, Trotta F, Pinnarelli L, Davoli M, Addis A. Neonatal outcomes following new reimbursement limitations on palivizumab in Italy. Arch Dis Child. 2018;103(12):1163–7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, Gambassi G, Ivanovic J, Ferrajolo C, Molokhia M, Ballard C, Sharp S, Sturkenboom M, Trifirò G. The effect of safety warnings on antipsychotic drug prescribing in elderly persons with dementia in the United Kingdom and Italy: a population-based study. CNS Drugs. 2016;30(11):1097–109.

    Article  CAS  PubMed  Google Scholar 

  12. Strengthening Pharmaceutical Systems (SPS) Program. 2009. Indicator-based pharmacovigilance assessment tool: manual for conducting assessments in developing countries. Submitted to the U.S. Agency for International Development by the SPS Program. Arlington: Management Sciences for Health.

Download references

Acknowledgements

The authors would like to thank all the other attendees of the workshop: Elena Arzenton, Gian Nicola Castiglione, Paola Cutroneo, Alessandra Del Porto, Armando Gennazzani, Carmen Ferrajolo, Olivia Leoni, Lorella Lombardozzi, Nadia Mores, Francesca Menniti-Ippolito, Pietro Minuz, Concetta Rafaniello, Carmela Santuccio, Giovanna Scroccaro, Liberata Sportiello, and Francesco Trotta. The authors would like to acknowledge the contribution of Cosimo Zaccaria to the writing of the paper. The authors would also like to acknowledge with gratitude the great contribution of Prof. Gianpaolo Velo, who passed away in 2017, to pharmacovigilance in Italy.

Author information

Authors and Affiliations

  1. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

    Janet Sultana & Gianluca Trifirò

  2. Veneto Regional Pharmacovigilance Centre, University of Verona, Piazzale Ludovico Antonio Scuro n.10, 37134, Verona, Italy

    Ugo Moretti, Mauro Venegoni & Roberto Leone

  3. Department of Epidemiology, Lazio Regional Health Service, Rome, Italy

    Antonio Addis

  4. Uppsala Monitoring Centre, Uppsala, Sweden

    Pia Caduff, Marie Lindquist & Daniele Sartori

  5. Campania Pharmacovigilance Regional Centre, Naples, Italy

    Annalisa Capuano

  6. Netherlands Pharmacovigilance Centre Lareb, WHO Collaborating Centre for Pharmacovigilance in Education and Patient Reporting, ‘s Hertogenbosch, The Netherlands

    Agnes Kant & Eugene van Puijenbroek

  7. Fundació Institut Català de Farmacologia, Hospital Vall d’Hebron, Autonomous University of Barcelona, Barcelona, Spain

    Joan-Ramon Laporte

  8. Medicines and Healthcare products Regulatory Agency, Canary Wharf, London, UK

    June Raine

  9. Toscana Pharmacovigilance Regional Centre, Pisa, Italy

    Marco Tuccori

Authors
  1. Janet Sultana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ugo Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Addis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pia Caduff
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Annalisa Capuano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Agnes Kant
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joan-Ramon Laporte
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marie Lindquist
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. June Raine
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Daniele Sartori
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Gianluca Trifirò
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Marco Tuccori
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mauro Venegoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Eugene van Puijenbroek
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Roberto Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Writing and revision of the manuscript: Janet Sultana, Ugo Moretti, Antonio Addis, Pia Caduff, Annalisa Capuano, Agnes Kant, Joan-Ramon Laporte, Marie Lindquist, June Raine, Daniele Sartori, Gianluca Trifirò, Marco Tuccori, Mauro Venegoni, Eugene van Puijenbroek and Roberto Leone.

Corresponding author

Correspondence to Roberto Leone.

Ethics declarations

Funding

The authors were not funded for their contribution to the present paper.

Conflict of interest

Janet Sultana, Ugo Moretti, Antonio Addis, Pia Caduff, Annalisa Capuano, Agnes Kant, Joan-Ramon Laporte, Marie Lindquist, June Raine, Daniele Sartori, Gianluca Trifirò, Marco Tuccori, Mauro Venegoni, Eugene van Puijenbroek and Roberto Leone have no conflicts of interest related to the present manuscript to declare. The present study was not funded, nor were the authors financially or otherwise compensated for their contribution to the present report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sultana, J., Moretti, U., Addis, A. et al. Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives. Drug Saf 42, 683–687 (2019). https://doi.org/10.1007/s40264-018-0768-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-018-0768-6

Search

Navigation